Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The functional consequences of intron retention: Alternative splicing coupled to NMD as a regulator of gene expression

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{3d87d79f56ee4a92b0deb95882b0e81d,
title = "The functional consequences of intron retention: Alternative splicing coupled to NMD as a regulator of gene expression",
abstract = "The explosion in sequencing technologies has provided us with an instrument to describe mammalian transcriptomes at unprecedented depths. This has revealed that alternative splicing is used extensively not only to generate protein diversity, but also as a means to regulate gene expression post-transcriptionally. Intron retention (IR) is overwhelmingly perceived as an aberrant splicing event with little or no functional consequence. However, recent work has now shown that IR is used to regulate a specific differentiation event within the haematopoietic system by coupling it to nonsense-mediated mRNA decay (NMD). Here, we highlight how IR and, more broadly, alternative splicing coupled to NMD (AS-NMD) can be used to regulate gene expression and how this is deregulated in disease. We suggest that the importance of AS-NMD is not restricted to the haematopoietic system but that it plays a prominent role in other normal and aberrant biological settings.",
author = "Ying Ge and Porse, {Bo T}",
note = "{\circledC} 2013 WILEY Periodicals, Inc.",
year = "2014",
doi = "10.1002/bies.201300156",
language = "English",
volume = "36",
pages = "236--43",
journal = "BioEssays",
issn = "0265-9247",
publisher = "John/Wiley & Sons Ltd",
number = "3",

}

RIS

TY - JOUR

T1 - The functional consequences of intron retention

T2 - Alternative splicing coupled to NMD as a regulator of gene expression

AU - Ge, Ying

AU - Porse, Bo T

N1 - © 2013 WILEY Periodicals, Inc.

PY - 2014

Y1 - 2014

N2 - The explosion in sequencing technologies has provided us with an instrument to describe mammalian transcriptomes at unprecedented depths. This has revealed that alternative splicing is used extensively not only to generate protein diversity, but also as a means to regulate gene expression post-transcriptionally. Intron retention (IR) is overwhelmingly perceived as an aberrant splicing event with little or no functional consequence. However, recent work has now shown that IR is used to regulate a specific differentiation event within the haematopoietic system by coupling it to nonsense-mediated mRNA decay (NMD). Here, we highlight how IR and, more broadly, alternative splicing coupled to NMD (AS-NMD) can be used to regulate gene expression and how this is deregulated in disease. We suggest that the importance of AS-NMD is not restricted to the haematopoietic system but that it plays a prominent role in other normal and aberrant biological settings.

AB - The explosion in sequencing technologies has provided us with an instrument to describe mammalian transcriptomes at unprecedented depths. This has revealed that alternative splicing is used extensively not only to generate protein diversity, but also as a means to regulate gene expression post-transcriptionally. Intron retention (IR) is overwhelmingly perceived as an aberrant splicing event with little or no functional consequence. However, recent work has now shown that IR is used to regulate a specific differentiation event within the haematopoietic system by coupling it to nonsense-mediated mRNA decay (NMD). Here, we highlight how IR and, more broadly, alternative splicing coupled to NMD (AS-NMD) can be used to regulate gene expression and how this is deregulated in disease. We suggest that the importance of AS-NMD is not restricted to the haematopoietic system but that it plays a prominent role in other normal and aberrant biological settings.

U2 - 10.1002/bies.201300156

DO - 10.1002/bies.201300156

M3 - Journal article

VL - 36

SP - 236

EP - 243

JO - BioEssays

JF - BioEssays

SN - 0265-9247

IS - 3

ER -

ID: 41970943